The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-bromophenyl)-3-(4-(2-(1-methyl-1H-benzo[d]imidazol-2-yl)ethyl)phenyl)urea ID: ALA4520451
PubChem CID: 46382346
Max Phase: Preclinical
Molecular Formula: C23H21BrN4O
Molecular Weight: 449.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(CCc2ccc(NC(=O)Nc3cccc(Br)c3)cc2)nc2ccccc21
Standard InChI: InChI=1S/C23H21BrN4O/c1-28-21-8-3-2-7-20(21)27-22(28)14-11-16-9-12-18(13-10-16)25-23(29)26-19-6-4-5-17(24)15-19/h2-10,12-13,15H,11,14H2,1H3,(H2,25,26,29)
Standard InChI Key: MHCJGKYOXVHJDJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.4543 -12.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4531 -13.4241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1612 -13.8330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1594 -12.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8680 -12.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8728 -13.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6528 -13.6680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1302 -13.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6451 -12.3435 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9099 -14.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9474 -12.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3518 -12.2879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1690 -12.2831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5797 -12.9903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3961 -12.9858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8013 -12.2752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3842 -11.5676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5691 -11.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6185 -12.2693 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0322 -12.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8494 -12.9681 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6287 -13.6847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2631 -13.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8585 -14.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2715 -15.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0896 -15.0789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4928 -14.3633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0775 -13.6620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8677 -15.7948 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.35Molecular Weight (Monoisotopic): 448.0899AlogP: 5.77#Rotatable Bonds: 5Polar Surface Area: 58.95Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.51CX Basic pKa: 5.82CX LogP: 5.80CX LogD: 5.79Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -1.63
References 1. Subramanian G, Zhu Y, Bowen SJ, Roush N, White JA, Huczek D, Zachary T, Javens C, Williams T, Janssen A, Gonzales A.. (2019) Lead identification and characterization of hTrkA type 2 inhibitors., 29 (22): [PMID:31610943 ] [10.1016/j.bmcl.2019.126680 ]